We found that compared with healthy donors (n = 5), SOCS3 expression was significantly down-regulated (which is below the minimal level of five healthy volunteers) in most of BMNCs from CML patients (12 of 15) (Fig. 1b). The gene discussed is SOCS3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.